Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates
Portfolio Pulse from
Haemonetics (HAE) reported Q2 earnings of $1.12 per share, surpassing the Zacks Consensus Estimate of $1.09. This marks an improvement from $0.99 per share a year ago.
November 07, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Haemonetics reported Q2 earnings of $1.12 per share, exceeding expectations and showing growth from last year's $0.99 per share.
The earnings report shows Haemonetics not only exceeded analyst expectations but also demonstrated year-over-year growth. This positive performance is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100